1. Zhao, Miao, Cheng, Xuewen, Chen, Lei, Xiong, Zhi-Qi, Chen, Wan-Jin. 2024. Antisense oligonucleotides enhance SLC20A2 expression and suppress brain calcification in a humanized mouse model. In Neuron, 112, 3278-3294.e7. doi:10.1016/j.neuron.2024.07.013. https://pubmed.ncbi.nlm.nih.gov/39121859/
2. Donzuso, Giulia, Mostile, Giovanni, Nicoletti, Alessandra, Zappia, Mario. 2019. Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features. In Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 40, 2251-2263. doi:10.1007/s10072-019-03998-x. https://pubmed.ncbi.nlm.nih.gov/31267306/
3. Ramos-Brossier, Mariana, Romeo-Guitart, David, Lanté, Fabien, Friedlander, Gérard, Oury, Franck. 2024. Slc20a1 and Slc20a2 regulate neuronal plasticity and cognition independently of their phosphate transport ability. In Cell death & disease, 15, 20. doi:10.1038/s41419-023-06292-z. https://pubmed.ncbi.nlm.nih.gov/38195526/
4. Ceylan, Ahmet Cevdet, Kireker Köylü, Oya, Özyürek, Hamit, Yön, Mehmet İlker, Kasapkara, Çiğdem Seher. 2022. Homozygous SLC20A2 mutations cause congenital CMV infection-like phenotype. In Acta neurologica Belgica, 123, 1757-1761. doi:10.1007/s13760-022-02044-6. https://pubmed.ncbi.nlm.nih.gov/35881308/